Advanced hepatocellular carcinoma: CT perfusion of liver and tumor tissue--initial experience.
about
Advances in computed tomography and magnetic resonance imaging of hepatocellular carcinomaAdvanced hepatocellular carcinoma and sorafenib: Diagnosis, indications, clinical and radiological follow-upPrognostication and response assessment in liver and pancreatic tumors: The new imagingChallenges of advanced hepatocellular carcinomaAssessment of clinical and radiological response to sorafenib in hepatocellular carcinoma patients¹⁸F-FDG PET metabolic parameters and MRI perfusion and diffusion parameters in hepatocellular carcinoma: a preliminary studyValue or waste: Perfusion imaging following radiofrequency ablation - early experience.Abdominal perfusion computed tomography.Imaging of hepatocellular carcinoma: diagnosis, staging and treatment monitoringRecent Advances in CT and MR Imaging for Evaluation of Hepatocellular CarcinomaImaging and Imaging-Guided Interventions in the Diagnosis and Management of Hepatocellular Carcinoma (HCC)-Review of Evidence.DCE-MRI of hepatocellular carcinoma: perfusion quantification with Tofts model versus shutter-speed model--initial experience.DCE-MRI of the liver: effect of linear and nonlinear conversions on hepatic perfusion quantification and reproducibilityPerfusion magnetic resonance imaging of the liver.Protocol modifications for CT perfusion (CTp) examinations of abdomen-pelvic tumors: impact on radiation dose and data processing time.Effect of pre-enhancement set point on computed tomographic perfusion values in normal liver and metastases to the liver from neuroendocrine tumors.Investigation of hepatic blood perfusion by laser speckle imaging and changes of hepatic vasoactive substances in mice after electroacupunctureHepatocellular carcinoma: perfusion quantification with dynamic contrast-enhanced MRIPerfusion measurements by micro-CT using prior image constrained compressed sensing (PICCS): initial phantom results.Perfusion characterization of liver metastases from endocrine tumors: Computed tomography perfusion.Metastases to the liver from neuroendocrine tumors: effect of duration of scan acquisition on CT perfusion valuesCT perfusion of the liver: principles and applications in oncology.Quantitative analysis of respiration-related movement for abdominal artery in multiphase hepatic CTReproducibility of CT perfusion parameters in liver tumors and normal liver.Correlations of 3T DCE-MRI quantitative parameters with microvessel density in a human-colorectal-cancer xenograft mouse model.Effect on perfusion values of sampling interval of computed tomographic perfusion acquisitions in neuroendocrine liver metastases and normal liver.HCC and angiogenesis: possible targets and future directionsCT perfusion as an imaging biomarker in monitoring response to neoadjuvant bevacizumab and radiation in soft-tissue sarcomas: comparison with tumor morphology, circulating and tumor biomarkers, and gene expression.CT Perfusion Imaging Can Predict Patients' Survival and Early Response to Transarterial Chemo-Lipiodol Infusion for Liver Metastases from Colorectal CancersPerfusion CT in colorectal cancer: comparison of perfusion parameters with tumor grade and microvessel densityANG1 treatment reduces muscle pathology and prevents a decline in perfusion in DMD mice.Comparison of free breathing versus breath-hold in perfusion imaging using dynamic volume CTNovel Imaging Diagnosis for Hepatocellular Carcinoma: Consensus from the 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014)The evaluation of haemodynamics in cirrhotic patients with spectral CT.Assessment of blood flow in hepatocellular carcinoma: correlations of computed tomography perfusion imaging and circulating angiogenic factorsEnhancement patterns of pancreatic adenocarcinoma on conventional dynamic multi-detector row CT: correlation with angiogenesis and fibrosisMorphological and functional MDCT: problem-solving tool and surrogate biomarker for hepatic disease clinical care and drug discovery in the era of personalized medicine.Computed tomography perfusion in evaluating the therapeutic effect of transarterial chemoembolization for hepatocellular carcinoma.Quantitative characterization of hepatocellular carcinoma and metastatic liver tumor by CT perfusion.Clinical application of hepatic CT perfusion.
P2860
Q26772334-3E64D9F6-6F08-4081-AEE2-0EFB70CF07D1Q26851033-2706ED0A-91A3-45FF-8B49-4E6FA162B2B2Q27021568-08E415A5-30A3-4C4F-B749-F7A33E59CA90Q28076867-8AB944AE-6492-4A77-B4F6-8F2847D7F024Q28086977-C5A209B5-C494-492A-A048-B2AAF385E6ECQ28687190-BF74C083-8B8C-48E9-8959-1419EE74D598Q30316097-574126DD-81FB-4181-9646-65FDA85A7794Q30420501-1F553453-514C-4E24-9A17-B2A9E993E84CQ30436747-BA260F6C-A051-4352-B27F-905BB36C7ACAQ30448049-F494ECF3-F245-4A1D-8CC9-B84E407E15E9Q30458257-34EEDE57-9E05-415A-9CCA-1CBD731F0C7EQ31030824-746F0699-8391-4DB6-B7D3-A4E9C83972D7Q33759248-DD5FEE4D-B774-4308-809F-6D65D46588D2Q33764784-D059B716-DC69-438D-8370-CCF87AF7DC56Q33796799-F1169831-65A2-4355-9275-34BFE7874183Q33911305-234A3E8D-28DC-4702-ADCC-D8E9D877BB16Q34029802-FD57DD39-7D94-422C-ACFD-993CB4E7CA5EQ34089545-3FE9154A-0EE1-4D18-8FA0-EB3D3EC75727Q34099422-5C78FA02-0C5C-4076-B968-E3D65195FB61Q34427108-B56BD50D-DAE2-4ECC-AD9E-112120585741Q34495280-CF89D4AF-8865-46C8-A807-A4F5EB67A20BQ34681040-EE0D2FA7-F35A-40EC-A8FB-FE65BF028080Q34764618-58373BD7-2827-4079-921E-1B16CA9F5592Q35167394-D20306EE-F895-474D-AC99-E991B78A828EQ35361001-DDE01499-7C01-482A-BBA8-241854DBEF8FQ35611338-8F12F009-ED37-4176-B578-A7EC0026F283Q35698574-20B815A9-4FD7-42B5-842B-7C76D35A3320Q35776891-0893B1EC-0492-4372-9C34-E2032D01F195Q35843666-5CD6E436-AD94-4904-83D0-4F589C27FC2EQ35925855-60ECB919-25DC-4CF7-9123-416292BCB651Q36320134-83ABDF34-6741-4405-B6E9-6D986AB7496EQ36347036-AE152CD5-7E97-4B3D-ADCB-65D80F13BE71Q36423114-363F5FE6-BC3E-49BE-84B3-E4E6EEAA8A16Q37099031-0C9BAE30-41C9-4420-AAD8-F70C166A5810Q37225055-A691BCC5-C7FD-447D-8218-22042F7673C1Q37250349-CF26920A-C75E-46D9-A8C5-074C9ABB9C32Q37356037-AE28839A-F81C-43C9-B0A5-7FB198FE40B8Q37356460-0A0172FF-40E1-484F-98DF-9A1D6EA70728Q37394878-74156944-970D-4A8C-A78A-F550D69A4478Q37402678-E4DC4BB9-FAC4-489A-8675-7EE8E384BC07
P2860
Advanced hepatocellular carcinoma: CT perfusion of liver and tumor tissue--initial experience.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Advanced hepatocellular carcin ...... or tissue--initial experience.
@en
type
label
Advanced hepatocellular carcin ...... or tissue--initial experience.
@en
prefLabel
Advanced hepatocellular carcin ...... or tissue--initial experience.
@en
P2093
P1433
P1476
Advanced hepatocellular carcin ...... or tissue--initial experience.
@en
P2093
Andrew X Zhu
Dushyant V Sahani
Nagaraj-Setty Holalkere
Peter R Mueller
P304
P356
10.1148/RADIOL.2433052020
P407
P577
2007-06-01T00:00:00Z